Buprenorphine Tablet
Product Images NDC 72162-1345

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 72162-1345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of buprenorphine hydrochloride, showing its molecular arrangement with labeled functional groups and bonds, consistent with the active ingredient buprenorphine in the product.*

FDA Label Image

Image (Buprenorphine 02)

An instructional illustration showing the placement of a sublingual tablet under the tongue inside the mouth. A hand is depicted placing the tablet beneath the tongue, with the mouth open and tongue lifted to highlight the correct tablet position.*

FDA Label Image

Label (Lbl721621345)

Label for Buprenorphine Sublingual Tablets, 8 mg strength, repackaged by Bryant Ranch Prepack, Inc., and manufactured by Purdue Pharma L.P. The label shows the NDC number 72162-1345-3, a 30 tablet count, and storage instructions. It includes warnings to keep out of reach of children and to dispense in child-resistant containers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.